Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Toward a statistically relevant calibration end point for prostate seed implants.

Rosenzweig DP, Schell MC, Yu Y.

Med Phys. 2000 Jan;27(1):144-50.

PMID:
10659750
2.

Dosimetric effects of needle divergence in prostate seed implant using 125I and 103Pd radioactive seeds.

Nath S, Chen Z, Yue N, Trumpore S, Peschel R.

Med Phys. 2000 May;27(5):1058-66.

PMID:
10841410
3.

Optimum timing for image-based dose evaluation of 125I and 103PD prostate seed implants.

Yue N, Chen Z, Peschel R, Dicker AP, Waterman FM, Nath R.

Int J Radiat Oncol Biol Phys. 1999 Nov 1;45(4):1063-72.

PMID:
10571216
4.

Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition.

Landry G, Reniers B, Murrer L, Lutgens L, Gurp EB, Pignol JP, Keller B, Beaulieu L, Verhaegen F.

Med Phys. 2010 Oct;37(10):5188-98.

PMID:
21089752
5.
6.

Isotope choice and the effect of edema on prostate brachytherapy dosimetry.

Butler WM, Merrick GS, Dorsey AT, Lief JH.

Med Phys. 2000 May;27(5):1067-75.

PMID:
10841411
7.

MCPI: a sub-minute Monte Carlo dose calculation engine for prostate implants.

Chibani O, Williamson JF.

Med Phys. 2005 Dec;32(12):3688-98.

PMID:
16475768
8.

Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose.

Raben A, Chen H, Grebler A, Geltzeiler J, Geltzeiler M, Keselman I, Litvin S, Sim S, Hanlon A, Yang J.

Int J Radiat Oncol Biol Phys. 2004 Dec 1;60(5):1631-8.

PMID:
15590195
9.

Dose rate constant and energy spectrum of interstitial brachytherapy sources.

Chen Z, Nath R.

Med Phys. 2001 Jan;28(1):86-96.

PMID:
11213926
10.
11.

A genetic algorithm for the optimization of prostate implants.

Yu Y, Schell MC.

Med Phys. 1996 Dec;23(12):2085-91.

PMID:
8994175
12.

Monte Carlo-aided dosimetry of the Symmetra model I25.S06 125I, interstitial brachytherapy seed.

Hedtjärn H, Carlsson GA, Williamson JF.

Med Phys. 2000 May;27(5):1076-85.

PMID:
10841412
13.

Comparison of seed loading approaches in prostate brachytherapy.

Butler WM, Merrick GS, Lief JH, Dorsey AT.

Med Phys. 2000 Feb;27(2):381-92.

PMID:
10718143
14.
15.

Dosimetric effects of seed anisotropy and interseed attenuation for 103Pd and 125I prostate implants.

Chibani O, Williamson JF, Todor D.

Med Phys. 2005 Aug;32(8):2557-66.

PMID:
16193786
16.

Effect of prostate size and isotope selection on dosimetric quality following permanent seed implantation.

Merrick GS, Butler WM, Dorsey AT, Lief JH.

Tech Urol. 2001 Sep;7(3):233-40.

PMID:
11575521
17.

Comparative study of permanent interstitial prostate brachytherapy post-implant evaluation among seven Italian institutes.

Mangili P, Stea L, Cattani F, Lappi S, Giglioli F, Calamia E, Ziglio F, Martinelli R, Longobardi B.

Radiother Oncol. 2004 Apr;71(1):13-21.

PMID:
15066291
18.

Focal prostate brachytherapy with (103)Pd seeds.

Butler WM, Merrick GS.

Phys Med. 2016 Mar;32(3):459-64. doi: 10.1016/j.ejmp.2016.03.012. Epub 2016 Apr 1.

PMID:
27053451
19.

Intraoperative dynamic dose optimization in permanent prostate implants.

Lee EK, Zaider M.

Int J Radiat Oncol Biol Phys. 2003 Jul 1;56(3):854-61.

PMID:
12788195
20.

Well-ionization chamber response relative to NIST air-kerma strength standard for prostate brachytherapy seeds.

Mitch MG, Zimmerman BE, Lamperti PJ, Seltzer SM, Coursey BM.

Med Phys. 2000 Oct;27(10):2293-6.

PMID:
11099196

Supplemental Content

Support Center